Fenofibrate
Top View
- And Bempedoic Acid/Ezetimibe (Nexlizet™) New Drug Update
- Development of a LC-MS/MS Method for the Estimation of Clinofibrate In
- Fenofibrate Toxicity and Impact on Clinical Biomarkers in Patients with Dyslipidaemia
- (Nos. 6122, 6123) NEW TRICOR ® 48 Mg and 145 Mg Rx Only DESCRIPTION TRICOR (Fenofibrate Tablets), Is a Lipid Regulating Agent A
- Zetia® (Ezetimibe) Tablets
- Fibricor (Fenofibric Acid) Tablets Label
- Fenofibrate and Derivatives
- Gemfibrozil May 2012
- PPAR Agonist Fenofibrate Suppresses Tumor Growth Through Direct
- Elucidation of Molecular Mechanism of a Selective PPAR Modulator
- Fenofibrate Capsules, Micronized
- Lipofen® (Fenofibrate Capsules USP) for Oral Use 50 Mg and 150 Mg
- Therapeutic Class Overview Bile Acid Sequestrants
- A Rigorous Machine Learning Classifier for GPCR Targeting
- LIPID LOWERING THERAPIES Llorente Serrano M, Sánchez Gundín J, Rueda Naharro A, Martí Gil C, Martínez Valdivieso L, Barreda Hernández D
- Summary of Product Characteristics
- Bile Acid Sequestrants • Niacin • Fibrates • Mipomersen • Lomitapide • LDL Apheresis Evidence for Treating All FH Patients
- What Are Effective Medication Combinations for Dyslipidemia?